Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.
Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD).
Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.
Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD).
Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD).
.jpg?lang=en-US&ext=.jpg)
